Myungmoon Phar - Asset Resilience Ratio

Latest as of December 2025: 0.11%

Myungmoon Phar (017180) has an Asset Resilience Ratio of 0.11% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Myungmoon Phar's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩309.32 Million

≈ $209.63K USD Cash + Short-term Investments

Total Assets

₩272.46 Billion

≈ $184.64 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2025)

This chart shows how Myungmoon Phar's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Myungmoon Phar.

Liquid Assets Composition Over Time

This chart breaks down Myungmoon Phar's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Myungmoon Phar long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩309.32 Million	0.11%
Total Liquid Assets	₩309.32 Million	0.11%

Asset Resilience Insights

Limited Liquidity: Myungmoon Phar maintains only 0.11% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Myungmoon Phar Industry Peers by Asset Resilience Ratio

Compare Myungmoon Phar's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Myungmoon Phar (2009–2025)

The table below shows the annual Asset Resilience Ratio data for Myungmoon Phar.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.11%	₩309.32 Million ≈ $209.63K	₩272.46 Billion ≈ $184.64 Million	-0.03pp
2024-12-31	0.14%	₩365.41 Million ≈ $247.63K	₩257.99 Billion ≈ $174.83 Million	-1.42pp
2023-12-31	1.57%	₩3.70 Billion ≈ $2.51 Million	₩236.55 Billion ≈ $160.31 Million	-0.66pp
2022-12-31	2.22%	₩5.13 Billion ≈ $3.47 Million	₩230.45 Billion ≈ $156.17 Million	+0.56pp
2021-12-31	1.66%	₩3.70 Billion ≈ $2.51 Million	₩222.68 Billion ≈ $150.90 Million	-1.85pp
2020-12-31	3.51%	₩8.53 Billion ≈ $5.78 Million	₩243.03 Billion ≈ $164.69 Million	+0.41pp
2019-12-31	3.10%	₩8.19 Billion ≈ $5.55 Million	₩264.44 Billion ≈ $179.21 Million	-0.35pp
2018-12-31	3.45%	₩8.39 Billion ≈ $5.68 Million	₩243.07 Billion ≈ $164.72 Million	+0.29pp
2017-12-31	3.16%	₩7.43 Billion ≈ $5.03 Million	₩235.08 Billion ≈ $159.31 Million	+1.07pp
2016-12-31	2.09%	₩4.62 Billion ≈ $3.13 Million	₩221.08 Billion ≈ $149.82 Million	-0.97pp
2015-12-31	3.07%	₩6.11 Billion ≈ $4.14 Million	₩199.42 Billion ≈ $135.14 Million	-1.22pp
2014-12-31	4.28%	₩8.17 Billion ≈ $5.53 Million	₩190.66 Billion ≈ $129.21 Million	-0.35pp
2013-12-31	4.64%	₩8.92 Billion ≈ $6.05 Million	₩192.41 Billion ≈ $130.39 Million	+0.53pp
2012-12-31	4.10%	₩7.73 Billion ≈ $5.24 Million	₩188.34 Billion ≈ $127.63 Million	+1.93pp
2011-12-31	2.18%	₩4.41 Billion ≈ $2.99 Million	₩202.50 Billion ≈ $137.23 Million	-3.91pp
2010-12-31	6.08%	₩9.99 Billion ≈ $6.77 Million	₩164.15 Billion ≈ $111.24 Million	+5.50pp
2009-12-31	0.58%	₩890.00 Million ≈ $603.14K	₩153.85 Billion ≈ $104.26 Million	--

pp = percentage points

About Myungmoon Phar

KO:017180 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$29.36 Million

₩43.32 Billion KRW

Market Cap Rank

#23948 Global

#1672 in Korea

Share Price

₩1276.00

Change (1 day)

-0.08%

52-Week Range

₩1057.00 - ₩1945.00

All Time High

₩10277.86